0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessAim of the present study was to assess changes in Ocrelizumab (OCR) schedule during the first wave of pandemic in Italy and to evaluate the effect of delayed infusion on clinic/radiological endpoints.
Alvino Bisecco, Federica Matrone, Marco Capobianco, Giovanna De Luca, Massimo Filippi, Franco Granella, Giacomo Lus, Girolama Alessandra Marfia, Massimiliano Mirabella, Francesco Patti, María Trojano, Agnese Mascolo, Massimiliano Copetti, Gioacchino Tedeschi, Antonio Gallo (2024). Covid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010). , 102(7_supplement_1), DOI: https://doi.org/10.1212/wnl.0000000000206347.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2024
Authors
15
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1212/wnl.0000000000206347
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
